YTEN - YIELD10 BIOSCIENCE, INC.
Previous close
2.91
2.910 100.000%
Share volume: 0
Last Updated: Wed 15 May 2024 08:02:02 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
4.47%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Fundamental analysis
9%
Profitability
0%
Dept financing
12%
Liquidity
67%
Performance
2%
Performance
5 Days
0 0%
1 Month
0 0%
3 Months
-6.29%
6 Months
-29.71%
1 Year
323.69%
2 Year
-47.89%
Key data
Company detail
CEO: Oliver P. Peoples
Region: US
Website: yield10bio.com
Employees: 30
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: yield10bio.com
Employees: 30
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Yield10 Bioscience, Inc. engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG.
Recent news